Harrison - Heart Failure and Cor Pulmonale Flashcards
HF - Number of people affected worldwide?
20 million.
Prevalence of HF in people over 65?
6-10%
What must happen in a patient to predispose to develop HF?
Any condition that leads to an alteration in LV structure or function.
Etiology of HF - 4 categories?
- Depressed ejection fraction (40-50%).
- Pulmonary heart disease
- High-output states
Etiology of HF - Depressed EF (<40%)?
- CAD –> MI, ischemia.
- Chronic pressure overload.
- Chronic volume overload.
- Non ischemic DCM
- Toxic/drug-induced damage.
- Chagas
- Disorders of rate and rhythm - chronic tachy/brady-arrhythmias.
Etiology of HF - Preserved EF (>40-50%)?
- Pathologic hypertrophy - primary (HCM), or secondary (HTN).
- Aging
- RCM
- Fibrosis
- Endomyocardial disorders
Etiology of HF - Pulmonary heart disease?
- Cor pulmonale
2. Pulmonary vascular disorders
Etiology of HF - High-output states?
- Metabolic disorders
- Thyrotoxicosis
- Nutritional disorders (beri beri)
- Excessive blood-flow requirements
- Systemic AV shunting
- Chronic anemia
MCC of HF?
CAD - Responsible for 60-75%.
HTN and HF?
HTN contributes to the development of HF in 75% of patients, including most patients with CAD.
Percentage of HF with a DEPRESSED EF in which the cause is unknown?
20-30%.
Conditions that lead to high CO - what is essential in order to result in HF?
The presence of underlying structural heart disease (usually).
Prognosis of symptomatic HF?
Poor:
30-40% die within 1yr.
60-70% die within 5yrs.
mainly from worsening of HF or as a sudden event (probably v-arrhythmia).
NYHA class IV - annual mortality rate?
30-70%.
NYHA class II - annual mortality rate?
5-10%.
NYHA class I - Objective assessment?
Patients with cardiac disease but without resulting limitation of physical activity.
Ordinary physical activity does not cause undue fatigue, palpitations, dyspnea, or anginal pain.
NYHA class II - Objective assessment?
- Patients with cardiac disease resulting in slight limitation of physical activity.
- They are comfortable at rest.
- Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.
NYHA class III - Objective assessment?
- Patients with cardiac disease resulting in marked limitation of physical activity.
- They are comfortable at rest.
- Less than ordinary activity causes fatigue, palpitation, dyspnea, or anginal pain.
NYHA class IV - Objective assessment?
- Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort.
- Symptoms of HF or the anginal syndrome may be present even at rest.
- If any physical activity is undertaken, discomfort is increased.
Index event in the pathogenesis of HF with a depressed EF?
Regardless of he nature of the inciting event, the feature that is common to each of these index events is that they ALL in some manner produce a decline in the pumping capacity of the heart.
After the initial decline in pumping activity, are the patients symptomatic?
In most instances, patients remain asymptomatic or minimally symptomatic after the initial decline in pumping activity of the heart or develop symptoms only after dysfunction has been present for some time.
At some point, asymptomatic patients become overtly symptomatic with a resultant striking increase in morbidity and mortality rates. What causes this transition?
Exact cause not known:
–> The transition to symptomatic HF is accompanied by increasing activation of neurohormonal adrenergic, and cytokine systems that lead to a series of adaptive changes within the myocardium collectively referred to as LV REMODELING.
Overview of LV remodeling - 3 categories of alterations?
- Alterations in myocyte biology
- Myocardial changes
- Alterations in LV chamber geometry
LV remodeling - Alternations in myocyte biology?
- Excitation-contraction coupling
- Myosin heavy chain (fetal) gene expression
- Beta adrenergic desensitization
- Hypertrophy
- Myocytolysis
- Cytoskeletal proteins
LV remodeling - Myocardial changes?
- Myocyte loss –> Necrosis/Apoptosis/Autophagy
2. Alterations in ECM –> Matrix degradation/Myocardial fibrosis
LV remodeling - Alterations in LV chamber geometry?
- LV dilation
- Incr. LV sphericity
- LV wall thining
- MV incompetence
Biologic stimuli for LV remodeling?
- Mechanical stretch of the myocyte
- Circulating neurohormones (NE, ANG II)
- Inflammatory cytokines
- Other peptides and GFs (endothelin)
- ROS
- -> Now you understand the benefit from ACEIs + beta blockers in HF.